EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Natural Compound CalebinA Suppresses Gemcitabine Resistance and Tumor Progression by Inhibiting Angiogenesis and Invasion Through NF-κB Signaling in Pancreatic Cancer

Yuki Eguchi, Yoichi Matsuo iD, Masaki Ishida, Yuriko Uehara, Saburo Sugita, Yuki Denda, Keisuke Nonoyama, Hiromichi Murase, Tomokatsu Kato, Kenta Saito, Takafumi Sato, Hiroyuki Sagawa und 5 weitere

Nutrients · 2025

DOI: 10.3390/nu17162641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Yuki Eguchi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Nagoya City University, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Deoxycytidine, Drug Resistance, Neoplasm, NF-kappa B. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previously, we established gemcitabine (Gem)-resistant pancreatic cancer (PaCa) cell lines and showed that the acquisition of Gem resistance is accompanied by enhanced activation of the inflammatory transcription factor nuclear factor-κB (NF-κB). In this study, we focus on CalebinA, a natural compound derived from the rhizomes of turmeric, known for its potent anti-inflammatory properties. It has been suggested that this compound may exert anticancer effects by downregulating the NF-κB signaling cascade. Therefore, we collaborated with Sabinsa Corporation, Japan, to explore its potential application in pancreatic cancer therapy.

Methods

We used gemcitabine-resistant pancreatic cell lines to demonstrate the effect of CalebinA on cell toxicity, invasiveness, cytokine levels, NF-κB p65 activity, and tube formation in angiogenesis. Tumor volume and histopathological analysis were used to analyze the effects of CalebinA on tumors induced by the subcutaneous injection of pancreatic cell lines in mice.

Results

Treatment with 10 μM CalebinA significantly inhibited NF-κB activity. Gem-resistant PaCa cells exhibited higher invasive and angiogenic capacities than non-resistant parental cells; however, these capacities were markedly suppressed by CalebinA. In vivo, intraperitoneal CalebinA administration every 3 days led to a significant reduction in tumor volume in mice bearing subcutaneous xenografts of the AsPC-1 pancreatic cancer cell line. Immunohistochemical analysis revealed that CalebinA suppressed the expression of Ki-67, CD31-positive microvessel density, and NF-κB p65.

Conclusions

These findings suggest that CalebinA holds promise as a novel therapeutic agent for Gem-resistant pancreatic cancer and may be a strong candidate for clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsDeoxycytidineDrug Resistance, NeoplasmNF-kappa BNeovascularization, PathologicGemcitabineAnimalsCell Line, TumorHumansSignal TransductionNeoplasm InvasivenessMiceMice, NudeDisease ProgressionXenograft Model Antitumor AssaysAntimetabolites, AntineoplasticAngiogenesis

Stichwörter der Autor:innen

CalebinANF-κBangiogenesisgemcitabine resistanceinvasionnatural compoundpancreatic cancer

Substanzen

DeoxycytidineGemcitabineNF-kappa BAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Nagoya City University, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.
  • Department of Gastroenterological Surgery, East Medical Center, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan.

ORCID-Profile: Yoichi Matsuo, Ryo Ogawa

Zitieren

APA

Eguchi, Y., Matsuo, Y., Ishida, M., Uehara, Y., Sugita, S., Denda, Y., Nonoyama, K., Murase, H., Kato, T., Saito, K., Sato, T., Sagawa, H., Yamakawa, Y., Ogawa, R., Takahashi, H., Mitsui, A., & Takiguchi, S. (2025). The Natural Compound CalebinA Suppresses Gemcitabine Resistance and Tumor Progression by Inhibiting Angiogenesis and Invasion Through NF-κB Signaling in Pancreatic Cancer. Nutrients. https://doi.org/10.3390/nu17162641

Vancouver

Eguchi Y, Matsuo Y, Ishida M, Uehara Y, Sugita S, Denda Y, et al. The Natural Compound CalebinA Suppresses Gemcitabine Resistance and Tumor Progression by Inhibiting Angiogenesis and Invasion Through NF-κB Signaling in Pancreatic Cancer. Nutrients. 2025. doi:10.3390/nu17162641

BibTeX
@article{Eguchi2025,
  author = {Eguchi, Yuki and Matsuo, Yoichi and Ishida, Masaki and Uehara, Yuriko and Sugita, Saburo and Denda, Yuki and Nonoyama, Keisuke and Murase, Hiromichi and Kato, Tomokatsu and Saito, Kenta and Sato, Takafumi and Sagawa, Hiroyuki and Yamakawa, Yushi and Ogawa, Ryo and Takahashi, Hiroki and Mitsui, Akira and Takiguchi, Shuji},
  title = {The Natural Compound CalebinA Suppresses Gemcitabine Resistance and Tumor Progression by Inhibiting Angiogenesis and Invasion Through NF-κB Signaling in Pancreatic Cancer},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17162641}
}
Kostenlos starten →